This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Petrik, J. Articles by Hill, D. J. Search for Related Content PubMed PubMed Citation Articles by Petrik, J. Articles by Hill, D. J.

Overexpression of Insulin-Like Growth Factor-II in Transgenic Mice Is Associated with Pancreatic Islet Cell Hyperplasia¹

Lawson Research Institute (J.P., E.A., T.J.M., D.J.H.), St. Joseph’s Health Centre, London, Ontario, N6A 4V2, Canada; Departments of Physiology (J.P., D.J.H.), Medicine (E.A., T.J.M., D.J.H.), Paediatrics (J.P., D.J.H.), Pharmacology and Toxicology (T.J.M.), and Biochemistry (T.J.M.), University of Western Ontario, London, Ontario, N6A 5A5, Canada; and Laboratory of Developmental Genetics and Imprinting (J.M.P., W.L.D., W.R.), The Babraham Institute, Cambridge CB2 4AT, United Kingdom

Address all correspondence and requests for reprints to: Dr. D. J. Hill, Lawson Research Institute, St. Joseph’s Health Centre, 268 Grosvenor Street, London, Ontario, Canada, N6A 4V2. E-mail: dhill{at}lri.stjosephs.london.on.ca

We have used an insulin-like growth factor (IGF)-II transgenic mouse model in which mouse IGF-II is widely overexpressed, resulting in increased fetal size and selective organ overgrowth, to investigate the effects on the development of the endocrine pancreas. Fetuses examined on day 19.5–20 of gestation had significantly elevated circulating levels of IGF-II, compared with control mice. The pancreatic islets in transgenic animals were of irregular shape and had a mean area five times greater than in controls, whereas the mean number of islets per tissue section was not altered. The size of individual endocrine cells was not altered. Although the islets in animals expressing the IGF-II transgene were considerably larger, immunohistochemistry for insulin and glucagon showed that the relative proportion of ß-cells was significantly less, and that of -cells was higher. Normal islet morphology was disrupted, with -cells appearing in small groups within the islets, as well as on the periphery, whereas ß-cells were often seen at the edge of the islets. Twice as many islet cells (21.9% vs. 11.4%) were involved in cell replication, detected by the presence of immunoreactive proliferating cell nuclear antigen, in pancreata from transgenic mice vs. controls, whereas the number of cells undergoing apoptosis was significantly reduced. Abundant IGF-II messenger RNA was found within the islets of transgenic animals by in situ hybridization, and the relative area of islets demonstrating immunoreactive IGF-II was significantly greater. Immunoreactive IGF-I was much less abundant and was further reduced in islets of transgenic animals. The area of islets immunopositive for IGF binding protein-2 was unaltered. Despite the presence of islet hyperplasia, circulating insulin levels and serum glucose levels were not significantly different between transgenic and control mice. These results show that an overexpression of IGF-II in fetal life has a profound effect on islet morphology and causes islet hyperplasia while reducing the attrition of islet cells by apoptosis.

This article has been cited by other articles:

				E. Estil.les, N. Tellez, J. Soler, and E. Montanya High sensitivity of {beta}-cell replication to the inhibitory effects of interleukin-1{beta}: modulation by adenoviral overexpression of IGF2 in rat islets J. Endocrinol., October 1, 2009; 203(1): 55 - 63. [Abstract] [Full Text] [PDF]

				D. Gniuli, A. Calcagno, M. E. Caristo, A. Mancuso, V. Macchi, G. Mingrone, and R. Vettor Effects of high-fat diet exposure during fetal life on type 2 diabetes development in the progeny J. Lipid Res., September 1, 2008; 49(9): 1936 - 1945. [Abstract] [Full Text] [PDF]

				M. P. Keller, Y. Choi, P. Wang, D. Belt Davis, M. E. Rabaglia, A. T. Oler, D. S. Stapleton, C. Argmann, K. L. Schueler, S. Edwards, et al. A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility Genome Res., May 1, 2008; 18(5): 706 - 716. [Abstract] [Full Text] [PDF]

				M. M. Bonaventura, P. N. Catalano, A. Chamson-Reig, E. Arany, D. Hill, B. Bettler, F. Saravia, C. Libertun, and V. A. Lux-Lantos GABAB receptors and glucose homeostasis: evaluation in GABAB receptor knockout mice Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E157 - E167. [Abstract] [Full Text] [PDF]

				A. M Ackermann and M. Gannon Molecular regulation of pancreatic {beta}-cell mass development, maintenance, and expansion J. Mol. Endocrinol., February 1, 2007; 38(2): 193 - 206. [Abstract] [Full Text] [PDF]

				H. Jiang, H. Zhu, X. Chen, Y. Peng, J. Wang, F. Liu, S. Shi, B. Fu, Y. Lu, Q. Hong, et al. TIMP-1 Transgenic Mice Recover From Diabetes Induced by Multiple Low-Dose Streptozotocin Diabetes, January 1, 2007; 56(1): 49 - 56. [Abstract] [Full Text] [PDF]

				I. Giurgea, C. Sempoux, C. Bellanne-Chantelot, M. Ribeiro, L. Hubert, N. Boddaert, J.-M. Saudubray, J.-J. Robert, F. Brunelle, J. Rahier, et al. The Knudson's Two-Hit Model and Timing of Somatic Mutation May Account for the Phenotypic Diversity of Focal Congenital Hyperinsulinism J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4118 - 4123. [Abstract] [Full Text] [PDF]

				P. M. Vuguin, M. H. Kedees, L. Cui, Y. Guz, R. W. Gelling, M. Nejathaim, M. J. Charron, and G. Teitelman Ablation of the Glucagon Receptor Gene Increases Fetal Lethality and Produces Alterations in Islet Development and Maturation Endocrinology, September 1, 2006; 147(9): 3995 - 4006. [Abstract] [Full Text] [PDF]

				H. Iwakura, K. Hosoda, C. Son, J. Fujikura, T. Tomita, M. Noguchi, H. Ariyasu, K. Takaya, H. Masuzaki, Y. Ogawa, et al. Analysis of Rat Insulin II Promoter-Ghrelin Transgenic Mice and Rat Glucagon Promoter-Ghrelin Transgenic Mice J. Biol. Chem., April 15, 2005; 280(15): 15247 - 15256. [Abstract] [Full Text] [PDF]

				J. A. McCann, Y. Q. Xu, R. Frechette, L. Guazzarotti, and C. Polychronakos The Insulin-Like Growth Factor-II Receptor Gene Is Associated with Type 1 Diabetes: Evidence of a Maternal Effect J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5700 - 5706. [Abstract] [Full Text] [PDF]

				E. A. Joanette, B. Reusens, E. Arany, S. Thyssen, R. C. Remacle, and D. J. Hill Low-Protein Diet during Early Life Causes a Reduction in the Frequency of Cells Immunopositive for Nestin and CD34 in Both Pancreatic Ducts and Islets in the Rat Endocrinology, June 1, 2004; 145(6): 3004 - 3013. [Abstract] [Full Text] [PDF]

				W. R. Bennett, T. E. Crew, J. M. W. Slack, and A. Ward Structural-proliferative units and organ growth: effects of insulin-like growth factor 2 on the growth of colon and skin Development, March 15, 2003; 130(6): 1079 - 1088. [Abstract] [Full Text] [PDF]

				C. Sempoux, Y. Guiot, K. Dahan, P. Moulin, M. Stevens, V. Lambot, P. d. Lonlay, J.-C. Fournet, C. Junien, F. Jaubert, et al. The Focal Form of Persistent Hyperinsulinemic Hypoglycemia of Infancy: Morphological and Molecular Studies Show Structural and Functional Differences With Insulinoma Diabetes, March 1, 2003; 52(3): 784 - 794. [Abstract] [Full Text] [PDF]

				A. Cebrian, A. Garcia-Ocana, K. K. Takane, D. Sipula, A. F. Stewart, and R. C. Vasavada Overexpression of Parathyroid Hormone-Related Protein Inhibits Pancreatic {beta}-Cell Death In Vivo and In Vitro Diabetes, October 1, 2002; 51(10): 3003 - 3013. [Abstract] [Full Text] [PDF]

				B. Duvillie, C. Currie, T. Chrones, D. Bucchini, J. Jami, R. L. Joshi, and D. J. Hill Increased Islet Cell Proliferation, Decreased Apoptosis, and Greater Vascularization Leading to {beta}-Cell Hyperplasia in Mutant Mice Lacking Insulin Endocrinology, April 1, 2002; 143(4): 1530 - 1537. [Abstract] [Full Text] [PDF]

				J. Nakae, Y. Kido, and D. Accili Distinct and Overlapping Functions of Insulin and IGF-I Receptors Endocr. Rev., December 1, 2001; 22(6): 818 - 835. [Abstract] [Full Text] [PDF]

				S. A. Kassem, I. Ariel, P. S. Thornton, K. Hussain, V. Smith, K. J. Lindley, A. Aynsley-Green, and B. Glaser p57KIP2 Expression in Normal Islet Cells and in Hyperinsulinism of Infancy Diabetes, December 1, 2001; 50(12): 2763 - 2769. [Abstract] [Full Text] [PDF]

				C. E Bertram and M. A Hanson Animal models and programming of the metabolic syndrome: Type 2 diabetes Br. Med. Bull., November 1, 2001; 60(1): 103 - 121. [Abstract] [Full Text] [PDF]

				A. L Fowden and D. J Hill Intra-uterine programming of the endocrine pancreas Br. Med. Bull., November 1, 2001; 60(1): 123 - 142. [Abstract] [Full Text] [PDF]

				B. Tyrberg, J. Ustinov, T. Otonkoski, and A. Andersson Stimulated Endocrine Cell Proliferation and Differentiation in Transplanted Human Pancreatic Islets: Effects of the ob Gene and Compensatory Growth of the Implantation Organ Diabetes, February 1, 2001; 50(2): 301 - 307. [Abstract] [Full Text]

				D. J. Hill, B. Strutt, E. Arany, S. Zaina, S. Coukell, and C. F. Graham Increased and Persistent Circulating Insulin-Like Growth Factor II in Neonatal Transgenic Mice Suppresses Developmental Apoptosis in the Pancreatic Islets Endocrinology, March 1, 2000; 141(3): 1151 - 1157. [Abstract] [Full Text] [PDF]